More recent observations related the responsiveness to anti-PD1 mAb with the abundance of tumor-infiltrating PD-1high/CTLA-4high CD8+ T cells, which may correspond to exhausted anti-melanoma-specific CTL [286]. This evidence concerns the gene CD8A and neoplasm.